ABCG2 and cancer: To detect the pathway affecting ABCG2 expression in OC cells, treatment of PI3K inhibitor LY294002 downregulated ABCG2 and Nrf2 expression, suggesting that the Nrf2–ABCG2 signal could be a common molecular cue that controls PDT effectiveness in cancers (Figure 1E).